| CAS NO: | 81919-14-4 |
| 规格: | 98% |
| 分子量: | 428.48 |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
[1]. Yin XX, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats.
m.cnreagent.com